Taysha Gene Therapies Inc... (TSHA)
1.63
0.01 (0.62%)
At close: Jan 15, 2025, 3:59 PM
1.63
0.31%
After-hours Jan 15, 2025, 04:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -1.84 | -0.59 | -2.5 | -10.9 | -798.24 |
| PS Ratio | 13.30 | 39.70 | n/a | n/a | n/a |
| PB Ratio | 2.74 | 104.67 | 4.60 | 1.87 | -6.59K |
| P/FCF Ratio | -2.56 | -0.88 | -3.16 | -11.78 | 6.59K |
| P/OCF Ratio | -2.81 | -1.12 | -3.75 | -15.26 | 6.59K |
| OCF/S Ratio | -4.73 | -35.33 | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.82 | 63.15 | 0.66 | n/a | n/a |
| Quick Ratio | 4.08 | 1.54 | 3.08 | 35.24 | 0.10 |
| Current Ratio | 4.08 | 1.54 | 3.08 | 35.24 | 0.10 |
| Asset Turnover | 0.09 | 0.02 | n/a | n/a | n/a |
| Interest Coverage | -14.49 | -42.77 | -121.34 | -1.54K | n/a |
| Return on Equity (ROE) | -1.49 | -178.69 | -1.84 | -0.17 | 8.26 |
| Return on Assets (ROA) | -0.65 | -1.34 | -0.82 | -0.17 | -74.33 |
| Return on Capital (ROIC) | -0.53 | -2.56 | -1.07 | -0.17 | 8.26 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 100.00% | 0.60% | n/a | n/a | n/a |
| Net Profit Margin | -722.06% | -6.78K% | n/a | n/a | n/a |
| Pretax Profit Margin | -722.06% | -6.64K% | n/a | n/a | n/a |
| Operating Profit Margin | -468.83% | -6.49K% | n/a | n/a | n/a |
| FCF Margin | -520.27% | -4.53K% | n/a | n/a | n/a |
| EBITDA Margin | -680.84% | -6.38K% | n/a | n/a | n/a |